Competitive Benchmarking of Eylea Market Share
  Evaluating the Eylea Market Share requires a comparison against other major players like Lucentis and Vabysmo. For years, aflibercept has held a dominant position due to its perceived superior durability and drying effect on the retina. However, the introduction of dual-pathway inhibitors has introduced new dynamics, forcing a re-evaluation of market hierarchies. To maintain its lead,...
0 Commentaires 0 Parts 1KB Vue 0 Aperçu